Literature DB >> 1346073

Renal artery stenosis caused by nonspecific arteritis (Takayasu disease): results of treatment with percutaneous transluminal angioplasty.

S Sharma1, A Saxena, K K Talwar, U Kaul, S N Mehta, M Rajani.   

Abstract

Renovascular hypertension is common in nonspecific aortoarteritis (Takayasu disease). The utility of percutaneous transluminal renal angioplasty in managing this disease has been reported infrequently, and technical problems in using this treatment method have not been described. We retrospectively evaluated the results of renal angioplasty in treating 33 stenoses in 20 patients. Each patient's diagnosis was based on the criteria established by the Aortitis Syndrome Research Committee of Japan. Criteria for selection of patients for angioplasty were (1) severe hypertension uncontrolled by single-drug therapy, (2) angiographic evidence of at least 70% stenosis of the renal artery with a pressure gradient of more than 20 mm Hg, and (3) a normal sedimentation rate. The transfemoral route was used to treat all 33 stenoses. Follow-up examinations included blood pressure and medication evaluation 1 day, 1 week, and 4-6 weeks after treatment, and thereafter at 6-month intervals. Technical success was obtained in 28 lesions (85%) in 17 patients (85%). All failures occurred in the presence of coexistent abdominal aortic disease and tight, proximal stenosis of the renal artery. Technical difficulties were attributed to the tough, noncompliant nature of the stenoses, which were difficult to cross and resisted repeated, prolonged balloon inflations. These patients experienced backache and a fall in systemic blood pressure during balloon inflation. In one patient, the ipsilateral renal vein was injured during angioplasty and required surgery. Clinical success was obtained in 14 (82%) of the 17 patients in whom technical success was achieved and included cure in six patients and improvement in eight others. Follow-up 1-18 months (mean, 8 months) after treatment showed restenosis in six (21%) of 28 lesions. We conclude that renal angioplasty in nonspecific arteritis is associated with technical difficulties; however, the short-term results are good and the complication rate is acceptable.

Entities:  

Mesh:

Year:  1992        PMID: 1346073     DOI: 10.2214/ajr.158.2.1346073

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  15 in total

1.  Takayasu's arteritis: clinical features and outcomes of 125 patients in China.

Authors:  Xiao-Liang Cong; Sheng-Ming Dai; Xiang Feng; Zhi-Wei Wang; Qing-Sheng Lu; Liang-Xi Yuan; Xian-Xian Zhao; Dong-Bao Zhao; Zai-Ping Jing
Journal:  Clin Rheumatol       Date:  2010-06-30       Impact factor: 2.980

2.  Emergency renal artery stenting in acute anuric renal failure in children with Takayasu's arteritis.

Authors:  Nageswara Rao Koneti; Nipun Mahajan; Shweta Bakhru; Sudeep Verma; Pallavi Kathare
Journal:  Indian Heart J       Date:  2013-09-05

3.  Chronic total occlusion and successful drug-eluting stent placement in Takayasu arteritis-induced renal artery stenosis.

Authors:  Guarav Agarwal; Hemender S Vats; Amish N Raval; Alexander S Yevzlin; Micah R Chan; Giorgio Gimelli
Journal:  Clin Med Res       Date:  2013-05-08

Review 4.  CSI position statement on management of heart failure in India.

Authors:  Santanu Guha; S Harikrishnan; Saumitra Ray; Rishi Sethi; S Ramakrishnan; Suvro Banerjee; V K Bahl; K C Goswami; Amal Kumar Banerjee; S Shanmugasundaram; P G Kerkar; Sandeep Seth; Rakesh Yadav; Aditya Kapoor; Ajaykumar U Mahajan; P P Mohanan; Sundeep Mishra; P K Deb; C Narasimhan; A K Pancholia; Ajay Sinha; Akshyaya Pradhan; R Alagesan; Ambuj Roy; Amit Vora; Anita Saxena; Arup Dasbiswas; B C Srinivas; B P Chattopadhyay; B P Singh; J Balachandar; K R Balakrishnan; Brian Pinto; C N Manjunath; Charan P Lanjewar; Dharmendra Jain; Dipak Sarma; G Justin Paul; Geevar A Zachariah; H K Chopra; I B Vijayalakshmi; J A Tharakan; J J Dalal; J P S Sawhney; Jayanta Saha; Johann Christopher; K K Talwar; K Sarat Chandra; K Venugopal; Kajal Ganguly; M S Hiremath; Milind Hot; Mrinal Kanti Das; Neil Bardolui; Niteen V Deshpande; O P Yadava; Prashant Bhardwaj; Pravesh Vishwakarma; Rajeeve Kumar Rajput; Rakesh Gupta; S Somasundaram; S N Routray; S S Iyengar; G Sanjay; Satyendra Tewari; Sengottuvelu G; Soumitra Kumar; Soura Mookerjee; Tiny Nair; Trinath Mishra; U C Samal; U Kaul; V K Chopra; V S Narain; Vimal Raj; Yash Lokhandwala
Journal:  Indian Heart J       Date:  2018-06-08

Review 5.  Large vessel vasculitis.

Authors:  Ashima Gulati; Arvind Bagga
Journal:  Pediatr Nephrol       Date:  2009-10-17       Impact factor: 3.714

6.  Renal vein injury during percutaneous transluminal renal angioplasty in nonspecific aortoarteritis.

Authors:  S Sharma; S Arya; S N Mehta; K K Talwar; M Rajani
Journal:  Cardiovasc Intervent Radiol       Date:  1993 Mar-Apr       Impact factor: 2.740

7.  Treatment of Takayasu's aortitis with self-expanding metallic stents (Gianturco stents) in two patients.

Authors:  S Sawada; N Tanigawa; M Kobayashi; N Morioka; K Kotani; T Senda; Y Okuda; Y Ohta
Journal:  Cardiovasc Intervent Radiol       Date:  1994 Mar-Apr       Impact factor: 2.740

8.  Influence of angiographic morphology on the acute and longer-term outcome of percutaneous transluminal angioplasty in patients with aortic stenosis due to nonspecific aortitis.

Authors:  S Sharma; S Shrivastava; S S Kothari; U Kaul; M Rajani
Journal:  Cardiovasc Intervent Radiol       Date:  1994 May-Jun       Impact factor: 2.740

Review 9.  Treatment of severe renal artery stenosis by percutaneous transluminal renal angioplasty and stent implantation: review of the pediatric experience: apropos of two cases.

Authors:  Kai König; Jutta Gellermann; Uwe Querfeld; Martin B E Schneider
Journal:  Pediatr Nephrol       Date:  2006-03-07       Impact factor: 3.714

10.  Hypertension without renovascular stenosis: a rare case of abdominal aorta coarctation treated with percutaneous transluminal angioplasty.

Authors:  Weiwei Ding; Wuxing Jiang; Ning Li; Jieshou Li
Journal:  Arch Med Sci       Date:  2012-02-29       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.